Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 101-106

  Caggiari, L ^a   Zanussi, S ^a   Bortolin, M T ^a   D'Andrea, M ^a   Nasti, G ^a   Simonelli, C ^a   Tirelli, U ^a   De Paoli, P ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Apoptosis; CD4 lymphocytes; HAART; HIV; IL 2

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL REGENERATION; CLINICAL ARTICLE; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIREMIA;

EID: 0034028857     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01187.x     Document Type: Article

References (34)

1. Fauci A. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-34.
2. Ho DD, Neumann A, Perelson AS, Chen W, Leonard J, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-6.
3. Wolters KC, Schuitemaker H, Miedema F. Rapid CD4+ T cell turnover in HIV-1 infection: a paradigm revisited. Immunol Today 1998; 19:44-48.
4. Hellerstein MK, McCune JM. T cell turnover in HIV disease. Immunity 1997; 7:583-9.
5. Amiesen JC. Programmed cell death and AIDS: from hypothesis to experiment. Immunol Today 1992; 13:388-91.
6. Samuelsson A, Brostom C, van Dijk N, Sonnenborg A, Chiodi F. Apoptosis of CD4+ and CD19+ cells during HIV-1 infection. Correlation with clinical progression, viral load and loss of humoral immunity. Virology 1997; 238:180-8.
7. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoisier M, Goujard C, Debord T, Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis correlates with lymphocyte activation and disease progression. J Immunol 1996; 156:3509-20.
8. Liegler T, Yonemoto W, Elbeik T, Vittinghof E, Buchbinder S, Greene WC. Diminished spontaneous apoptosis in lymphocytes from HIV-infected long term non progressors. J Infect Dis 1998; 178:669-79.
9. Prati E, Gorla R, Malacarne F et al. Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. AIDS Res Hum Retrovir 1997; 13:1501-8.
10. Meyaard L, Otto S, Jonker R, Mijnster M, Keet R, Miedema F. Programmed cell death of T cells in HIV-1 infection. Science 1992; 257:217-9.
11. Clerici M, Sarin A, Coffman R et al. Type1/type2 cytokine modulation of T-cell programmed cell death as a model for HIV pathogenesis. Proc Natl Acad Sci USA 1994; 91:11811-5.
12. Pakker N, Notermans DW, De Boer RJ et al. Byphasic kinetics of peripheral blood T cells after triple combination therapy in HIV infection: a composite of redistribution and proliferation. Nature Med 1998; 4:208-14.
13. Roederer M. Getting to the HAART of T cell dynamics. Nature Med 1998; 4:145-6.
14. McCune JM, Loftus R, Schmidt DK et al. High prevalence of thymic tissue in adults with HIV infection. J Clin Invest 1998; 101:2301-8.
15. Dybul M, Kinter A, Ruiz M, Fauci AS. Promethean thymus? J Clin Invest 1998; 101:2299-300.
16. Nokta M, Rossero R, Nichols J, Rosembaum M, Pollard RB. Effect of ddI, stavudine and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations. AIDS Res Hum Retrovir 1999; 15:255-64.
17. Johnson S, Parkin JM. Antiretroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 1998; 113:229-34.
18. Connors M, Kovacs JA, Krevat S et al. HIV infection induces changes in CD4 T cell-phenotype and depletions within CD4 T cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997; 3:533-40.
19. De Paoli P, Zanussi S, Simonelli C et al. Effects of subcutaneous interleukin-2 therapy on CD4 lymphocyte subsets and in vitro cytokine production in HIV+ subjects. J Clin Invest 1997; 100:2737-43.
20. Emery S, Lane HC. Immune reconstitution in HIV infection. Curr Opin Immunol 1997; 9:568-72.
21. Simonelli C, Zanussi S, Sandri S et al. Concomitant therapy with s.c. IL-2 and zidovudine plus didanosine in patients with early stage HIV infection. J Acquir Immune Defic Syndr Hum Retrovir 1999; 20:20-27.
22. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 4:1-19.
23. Zanussi S, Simonelli C, Bortolin MT et al. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with HAART or HAART + IL-2. Clin Exp Immunol 1999; 116:486-92.
24. Gorczyka W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in apoptotic cells by in situ TDT and nick translation assays. Cancer Res 1993; 53:1945-51.
25. McCloskey T, Chavan S, Lakshmi-Tamma S, Pahwa S. Comparison of seven quantitative assays to assess lymphocyte cell death during HIV infection: measurement of induced apoptosis in anti-Fas treated Jurkat cells and spontaneous apoptosis in peripheral blood mononuclear cells from children infected with HIV. AIDS Res Hum Retrovir 1998; 14:1413-22.
26. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184:39-51.
27. Carbonari M, Cibati M, Cherchi M, Sbarigia D, Pesce A, Dell'Anna L, Modica A, Fiorilli M. Detection and characterization of apoptotic PBL in HIV infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 1994; 83:1268-77.
28. Armitage P, Berry G. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987.
29. Zhang Z, Notermans D, Sedgewick G et al. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV infection. Proc Natl Acad Sci USA 1998; 95:1154-9.
30. Furtado M, Callaway D, Phair J, Kunstman K, Stanton J, Macken C, Perelson A, Wolinsky S. Persistence of HIV transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy. New Engl J Med 1999; 340:1614-22.
31. Natarajan V, Bosche M, Metcalf J, Ward D, Lane HC, Kovacs J. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Lancet 1999; 353:119-20.
32. Veis DJ, Sorenson C, Shutter J, Korsmeyer S. Bcl-2 deficient mice demonstrated fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 1993; 75:229-35.
33. Adachi Y, Oyazu N, Than S, McCloskey T, Pahwa S. IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection. J Immunol 1996; 157:4184-93.
34. Douek DC, McFarland R, Keiser P et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998; 396:690-5.